Molecular targets of prostate cancer, including prostate-specific antigen (PSA), prostate-specific membrane antigen (PSMA), and prostate cancer lipid antigen, are products of prostate cells and are used as potential NP targets (Cheng et al., 2012; Sanna and Sechi, 2012). Here, KLK3 is linked to prostate cancer.